JDRF and Amylin to Test Hormone for Blood Glucose Control

JDRF and Amylin are enthusiastic about the potential of metreleptin to help improve blood glucose control in people with type 1 diabetes. A successful outcome in the metreleptin study would likely lead to studies with larger numbers of people and the development of alternative treatments to using medical insulin alone.